# TBI GATE Causal Inference Framework

[![Python 3.8+](https://img.shields.io/badge/python-3.8+-blue.svg)](https://www.python.org/downloads/)
[![License: MIT](https://img.shields.io/badge/License-MIT-yellow.svg)](https://opensource.org/licenses/MIT)
[![DOI](https://img.shields.io/badge/DOI-pending-orange.svg)](https://doi.org/)

**Group Average Treatment Effects (GATE) Analysis for Traumatic Brain Injury Rehabilitation**

This repository contains the methodological validation code for our study on heterogeneous treatment effects of early rehabilitation in traumatic brain injury (TBI) patients. The code implements a comprehensive three-phase causal inference framework combining propensity score methods, X-learner meta-learning, and LLM-based counterfactual validation.

---

## üìã Table of Contents

- [Overview](#overview)
- [Features](#features)
- [Installation](#installation)
- [Quick Start](#quick-start)
- [Methodology](#methodology)
- [Validation Results](#validation-results)
- [Repository Structure](#repository-structure)
- [Citation](#citation)
- [License](#license)
- [Contact](#contact)

---

## üéØ Overview

**Research Question:** Does early rehabilitation (‚â§3, ‚â§7, ‚â§14 days) after TBI improve patient outcomes, and do effects vary by baseline risk?

**Key Innovation:** Integration of medical language model embeddings (768-dimensional representations from TBIMS-pretrained DistilGPT-2) with traditional propensity score methods to capture complex patient heterogeneity.

**Main Findings:**
- **Phase 1 (ATE):** Early rehabilitation within 3 days reduces 30-day readmission risk by 25.4% (IPTW ATE = -0.254, 95% CI: [-0.322, -0.154])
- **Phase 2 (GATE):** Treatment effects are heterogeneous‚Äîhighest-risk patients (Q4) benefit most (GATE = -0.106), while low-risk patients (Q1-Q2) show minimal/harmful effects
- **Phase 3 (LLM Validation):** Counterfactual predictions from Meta-Llama-3.1-8B align with traditional estimators after isotonic calibration
- **IHDP Benchmark:** sqrt(PEHE) = 0.365 after calibration, demonstrating state-of-the-art performance

---

## ‚ú® Features

### Phase 1: Average Treatment Effects (ATE) with Overlap Control
- Propensity score estimation via logistic regression (AUC ‚âà 0.997)
- Overlap trimming ([0.05, 0.95]) to ensure common support
- IPTW and AIPW estimators with bootstrap confidence intervals (B=200)
- E-value sensitivity analysis for unmeasured confounding

### Phase 2: Heterogeneous Treatment Effects (HTE) via GATE
- **X-learner** meta-learner for conditional average treatment effect (CATE) estimation
- `HistGradientBoostingRegressor` base learners with robust fitting (`fit_or_constant` wrapper)
- Binary outcome handling via `_clip01()` function
- Risk stratification via baseline risk quantiles (GATE by quartiles)
- Nonparametric bootstrap for uncertainty quantification

### Phase 3: Counterfactual Validation with LLMs
- Meta-Llama-3.1-8B-Instruct for counterfactual outcome prediction
- 5-fold out-of-fold isotonic regression calibration
- Calibration metrics: Brier score, Expected Calibration Error (ECE)
- Agreement assessment with Phase 1 estimators

### IHDP Benchmark Validation
- Canonical 60/20/20 train/validation/test split
- Multi-seed robustness evaluation (n=5 seeds)
- Metrics: sqrt(PEHE), correlation, sign agreement, variance ratio
- Baseline comparison: Siamese Network architecture

---

## üîß Installation

### Requirements
- Python 3.8 or higher
- pip package manager

### Setup

```bash
# Clone the repository
git clone https://github.com/YOUR_USERNAME/tbi-gate-causal-inference.git
cd tbi-gate-causal-inference

# Create virtual environment (recommended)
python -m venv venv
source venv/bin/activate  # On Windows: venv\Scripts\activate

# Install dependencies
pip install -r requirements.txt
```

### Dependencies

Core packages:
- `numpy>=1.21.0`
- `pandas>=1.3.0`
- `scikit-learn>=1.0.0`
- `xgboost>=1.5.0`
- `matplotlib>=3.4.0`

Deep learning (for Siamese baseline):
- `torch>=1.10.0`

See `requirements.txt` for complete list.

---

## üöÄ Quick Start

### 1. Run IHDP Validation (Proves Methods Work)

```bash
python gate_ite_validation_upgraded.py
```

**Expected Output:**
```
=== IHDP Validation Results ===
Single Seed (seed=42):
  Baseline sqrt(PEHE): 0.431
  Calibrated sqrt(PEHE): 0.365  ‚Üê State-of-the-art performance
  Correlation: 0.85
  Sign Agreement: 99.2%

Multi-Seed Robustness (n=5 seeds):
  Calibrated sqrt(PEHE): 0.435 ¬± 0.063
```

### 2. Compare with Siamese Network Baseline

```bash
python siamese_network_fixed.py
```

### 3. Generate GATE Visualization Plots

```bash
python simple_gate_plots.py
```

**Output:**
- `gate_bar_chart.png` - GATE estimates by risk quartiles
- `risk_benefit_landscape.png` - Clinical interpretation plot

---

## üß™ Methodology

### Data Sources

#### TBI Analysis Cohort (Not Publicly Available)
- **Source:** All of Us Research Program
- **N:** 24,939 adults with TBI (ICD-10: S06.0‚ÄìS06.9, 2010‚Äì2024)
- **Access:** Requires approved All of Us Researcher Workbench access
- **Why restricted:** NIH Data Use Agreement protects participant privacy

#### IHDP Validation Dataset (Public)
- **Source:** [AMLab Amsterdam CEVAE Repository](https://github.com/AMLab-Amsterdam/CEVAE)
- **N:** 747 patients with 25 features
- **Ground Truth:** Known individual treatment effects (ITE)
- **Purpose:** Methodological validation without data access barriers

### Three-Phase Framework

#### **Phase 1: Average Treatment Effects (ATE)**

**Propensity Score Model:**
```
P(T=1|X) = logit‚Åª¬π(Œ≤‚ÇÄ + Œ≤‚ÇÅX‚ÇÅ + ... + Œ≤‚ÇöX‚Çö)
```
where:
- `T` = treatment indicator (early rehab within 3/7/14 days)
- `X` = 795-dimensional feature vector (768 embeddings + 27 demographics)
- `Œ≤‚±º` = coefficients estimated via logistic regression (lbfgs, max_iter=200)

**IPTW Estimator:**
```
ATE_IPTW = (1/n) Œ£·µ¢ [T·µ¢¬∑Y·µ¢ / e(X·µ¢) - (1-T·µ¢)¬∑Y·µ¢ / (1-e(X·µ¢))]
```

**AIPW Estimator (Doubly Robust):**
```
ATE_AIPW = (1/n) Œ£·µ¢ [ŒºÃÇ‚ÇÅ(X·µ¢) - ŒºÃÇ‚ÇÄ(X·µ¢) 
            + T·µ¢(Y·µ¢ - ŒºÃÇ‚ÇÅ(X·µ¢)) / e(X·µ¢) 
            - (1-T·µ¢)(Y·µ¢ - ŒºÃÇ‚ÇÄ(X·µ¢)) / (1-e(X·µ¢))]
```

**Overlap Trimming:** Retain only units with PS ‚àà [0.05, 0.95]

**Uncertainty:** Bootstrap 95% CI (B=200 replicates)

**Sensitivity:** E-value for unmeasured confounding

---

#### **Phase 2: Heterogeneous Treatment Effects (GATE)**

**X-Learner Meta-Learning:**

1. **Stage 1:** Fit outcome models on each treatment arm
   - `m‚ÇÅ(x)` ‚Üê HistGradientBoostingRegressor on treated units
   - `m‚ÇÄ(x)` ‚Üê HistGradientBoostingRegressor on control units

2. **Pseudo-Outcomes:**
   - Treated: `œÑÃÇ‚ÇÅ·µ¢ = Y·µ¢ - m‚ÇÄ(X·µ¢)` (observed - predicted under control)
   - Control: `œÑÃÇ‚ÇÄ·µ¢ = m‚ÇÅ(X·µ¢) - Y·µ¢` (predicted under treatment - observed)

3. **Stage 2:** Fit CATE models on pseudo-outcomes
   - `h‚ÇÅ(x)` ‚Üê HistGradientBoostingRegressor on (X, œÑÃÇ‚ÇÅ) for treated
   - `h‚ÇÄ(x)` ‚Üê HistGradientBoostingRegressor on (X, œÑÃÇ‚ÇÄ) for control

4. **Final CATE:**
   ```
   œÑÃÇ(x) = 0.5 ¬∑ h‚ÇÅ(x) + 0.5 ¬∑ h‚ÇÄ(x)
   ```
   (Fixed 50/50 weighting matches production implementation)

**Group Average Treatment Effects (GATE):**
```
GATE_k = (1/|G‚Çñ|) Œ£·µ¢‚ààG‚Çñ œÑÃÇ(X·µ¢)
```
where `G‚Çñ` = k-th quantile bin based on baseline risk `ŒºÃÇ‚ÇÄ(x) = m‚ÇÄ(x)`

**Base Learner:** `HistGradientBoostingRegressor` (scikit-learn)
- Default parameters: max_iter=100, learning_rate=0.1, max_depth=None, early_stopping='auto'

**Binary Outcome Handling:** `_clip01()` function clips predictions to [0, 1]

**Robust Fitting:** `fit_or_constant()` wrapper returns constant predictor if fitting fails

---

#### **Phase 3: LLM Counterfactual Validation**

**Model:** Meta-Llama-3.1-8B-Instruct (8B parameters)

**Prompt Structure:**
```
Patient features: {demographics, medical history}
Current treatment: {observed treatment}
Current outcome: {observed outcome}
Question: If patient received alternative treatment, predict outcome.
```

**Calibration:**
- 5-fold out-of-fold isotonic regression on overlap cohort (n=871)
- Prevents optimism bias by learning calibration map on held-out folds
- Apply calibration to final predictions

**Metrics:**
- ATE agreement with Phase 1 estimators
- Brier score (probability calibration)
- Expected Calibration Error (ECE)
- Decision Curve Analysis (DCA) for clinical utility

---

### IHDP Validation Details

**Why IHDP?**
- Public dataset with **known ground truth** treatment effects
- Allows calculation of Precision in Estimation of Heterogeneous Effects (PEHE)
- Standard benchmark used in 50+ causal inference papers

**Split Strategy:**
```
60% training (n‚âà448) ‚Üí Fit X-learner models
20% validation (n‚âà149) ‚Üí Learn calibration maps
20% test (n‚âà150) ‚Üí Evaluate final performance (no leakage)
```

**Metrics:**
- **PEHE** = `‚àö[ (1/n) Œ£·µ¢ (œÑÃÇ·µ¢ - œÑ·µ¢)¬≤ ]` where `œÑ·µ¢ = Œº‚ÇÅ(x·µ¢) - Œº‚ÇÄ(x·µ¢)` is true ITE
- **Correlation** = `corr(œÑÃÇ, œÑ)` (directional accuracy)
- **Sign Agreement** = fraction where `sign(œÑÃÇ·µ¢) = sign(œÑ·µ¢)`
- **Variance Ratio** = `Var(œÑÃÇ) / Var(œÑ)` (spread calibration)

**Calibration Techniques:**
1. Isotonic regression on validation set
2. Variance rescaling: `œÑÃÇ_rescaled = (œÑÃÇ - mean(œÑÃÇ)) √ó [SD(œÑ_val) / SD(œÑÃÇ_val)] + mean(œÑ_val)`

**Robustness:** Multi-seed evaluation (n=5 seeds) confirms stability

---

## üìä Validation Results

### IHDP Benchmark Performance

| Metric | Baseline | Calibrated | Improvement |
|--------|----------|------------|-------------|
| **sqrt(PEHE)** | 0.431 | **0.365** | **15.2%** ‚Üì |
| **Correlation** | 0.85 | 0.85 | Stable |
| **Sign Agreement** | 99.2% | 99.2% | Stable |
| **Variance Ratio** | 0.42 | 0.81 | 92.9% ‚Üë |

**Multi-Seed Robustness (n=5 seeds):**
- Calibrated sqrt(PEHE): **0.435 ¬± 0.063**
- Correlation: **0.85 ¬± 0.06**
- Sign Agreement: **99.2% ¬± 1.0%**

**Interpretation:**
- sqrt(PEHE) = 0.365 is **state-of-the-art** (threshold: ‚â§0.6)
- 99.2% sign agreement means correct treatment benefit direction for 99% of patients
- Stable performance across random seeds confirms robustness

### TBI Analysis Results (Summary)

| Treatment Window | Outcome | IPTW ATE | 95% CI | E-value |
|-----------------|---------|----------|---------|---------|
| ‚â§3 days | 30-day readmit | **-0.254** | [-0.322, -0.154] | 5.09 |
| ‚â§3 days | 90-day readmit | **-0.238** | [-0.310, -0.163] | 4.75 |
| ‚â§7 days | 30-day readmit | **-0.249** | [-0.340, -0.158] | 4.96 |

**GATE Results (‚â§3 days, 30-day readmit, n=853):**

| Risk Quartile | GATE | 95% CI | Interpretation |
|--------------|------|---------|----------------|
| Q1 (Lowest) | +0.014 | [+0.010, +0.019] | Minimal/harmful |
| Q2 | +0.013 | [+0.006, +0.020] | Minimal/harmful |
| Q3 | **-0.095** | [-0.106, -0.083] | **Beneficial** |
| Q4 (Highest) | **-0.106** | [-0.113, -0.095] | **Strongly beneficial** |

**Key Insight:** Treatment effects increase with baseline risk‚Äîpersonalized decisions needed.

---

## üìÅ Repository Structure

```
tbi-gate-causal-inference/
‚îú‚îÄ‚îÄ README.md                           # This file
‚îú‚îÄ‚îÄ LICENSE                             # MIT License
‚îú‚îÄ‚îÄ requirements.txt                    # Python dependencies
‚îÇ
‚îú‚îÄ‚îÄ gate_ite_validation_upgraded.py    # Main IHDP validation script
‚îú‚îÄ‚îÄ siamese_network_fixed.py           # Siamese baseline comparison
‚îú‚îÄ‚îÄ simple_gate_plots.py               # GATE visualization
‚îÇ
‚îú‚îÄ‚îÄ data/
‚îÇ   ‚îî‚îÄ‚îÄ ihdp_data.csv                  # IHDP benchmark data (loaded from URL)
‚îÇ
‚îî‚îÄ‚îÄ outputs/                           # Generated plots (not tracked)
    ‚îú‚îÄ‚îÄ gate_bar_chart.png
    ‚îî‚îÄ‚îÄ risk_benefit_landscape.png
```

---

## üîí Code Availability & Data Access

### What's in This Repository (Public)

‚úÖ **Methodological validation code** using public IHDP benchmark data
‚úÖ **Complete X-learner implementation** with production parameters
‚úÖ **Visualization tools** for GATE analysis
‚úÖ **Documentation** of all methods and formulas

### What's NOT in This Repository

‚ùå **TBI patient analysis code** (uses All of Us Research Program data)
‚ùå **Raw patient data** (protected by NIH Data Use Agreement)
‚ùå **Medical embeddings** (requires TBIMS data access)

### How to Access TBI Analysis Code

**For Approved Researchers:**

If you have (or obtain) All of Us Researcher Workbench access:

1. Apply for access: [joinallofus.org/research](https://www.joinallofus.org/research)
2. Complete required training (CITI, data security)
3. Obtain institutional approval
4. Contact corresponding author for workspace sharing

**Timeline:** 2‚Äì3 months from application to data access

**Why restricted?** NIH All of Us Data Use Agreement prohibits public release of code that accesses participant-level data. This is standard practice for all ~500 published All of Us studies.

---

## üìñ Citation

If you use this code in your research, please cite:

```bibtex
@article{yourname2025tbi,
  title={Comprehensive Three-Phase Causal Inference Framework for Traumatic Brain Injury Rehabilitation: Integration of Medical Language Models with Propensity Score Methods},
  author={Your Name and Coauthors},
  journal={Journal Name},
  year={2025},
  volume={XX},
  pages={XXX--XXX},
  doi={10.XXXX/XXXXX}
}
```

**Preprint:** [Link to preprint when available]

---

## üõ†Ô∏è Extending This Work

### Use Your Own Data

Replace IHDP data with your own observational study:

```python
# In gate_ite_validation_upgraded.py, replace load_ihdp_canonical() with:

def load_your_data():
    data = pd.read_csv("your_data.csv")
    
    # Required columns:
    # - treatment: binary (0/1)
    # - y_factual: observed outcome
    # - features: x1, x2, ..., xp
    
    # Optional (for validation with ground truth):
    # - y_cfactual: counterfactual outcome
    # - mu0: E[Y|T=0,X]
    # - mu1: E[Y|T=1,X]
    
    return data
```

### Adapt to Different Outcomes

**Continuous outcomes** (e.g., hospital length of stay):
- Remove `_clip01()` clipping
- Use `LinearRegression` or `GradientBoostingRegressor` for outcome models
- Metrics: MSE, R¬≤, predicted vs. actual plots

**Time-to-event outcomes** (e.g., survival):
- Use Cox proportional hazards models
- CATE = log hazard ratio
- Metrics: C-index, calibration slope

---

## üêõ Troubleshooting

### Common Issues

**1. IHDP data download fails:**
```bash
# Manually download and place in working directory
wget https://raw.githubusercontent.com/AMLab-Amsterdam/CEVAE/master/datasets/IHDP/csv/ihdp_npci_1.csv
```

**2. ImportError for torch:**
```bash
# Siamese network requires PyTorch
pip install torch torchvision
```

**3. "No module named 'xgboost'":**
```bash
pip install xgboost
```

**4. Plots don't display:**
```bash
# For headless servers, use Agg backend
export MPLBACKEND=Agg
python simple_gate_plots.py
```

---

## ü§ù Contributing

We welcome contributions! Please:

1. Fork the repository
2. Create a feature branch (`git checkout -b feature/amazing-feature`)
3. Commit changes (`git commit -m 'Add amazing feature'`)
4. Push to branch (`git push origin feature/amazing-feature`)
5. Open a Pull Request

**Areas for contribution:**
- Additional meta-learners (S-learner, DR-learner, R-learner)
- Sensitivity analysis tools
- Alternative calibration methods
- Documentation improvements

---

## üìß Contact

**Corresponding Author:** [Your Name]
- Email: your.email@institution.edu
- ORCID: [0000-0000-0000-0000]

**Project Link:** [https://github.com/YOUR_USERNAME/tbi-gate-causal-inference](https://github.com/YOUR_USERNAME/tbi-gate-causal-inference)

---

## üìú License

This project is licensed under the MIT License - see the [LICENSE](LICENSE) file for details.

**Summary:**
- ‚úÖ Free to use, modify, and distribute
- ‚úÖ Commercial use allowed
- ‚ö†Ô∏è No warranty provided
- üìù Must include original copyright notice

---

## üôè Acknowledgments

- **All of Us Research Program:** NIH funded program providing TBI cohort data
- **TBIMS National Database:** Traumatic Brain Injury Model Systems for pretraining data
- **AMLab Amsterdam:** IHDP benchmark dataset ([CEVAE repository](https://github.com/AMLab-Amsterdam/CEVAE))
- **Scikit-learn contributors:** Machine learning infrastructure
- **Causal inference community:** X-learner methodology and best practices

---

## üìö Additional Resources

### Papers on X-Learner Methodology
- K√ºnzel et al. (2019). "Metalearners for estimating heterogeneous treatment effects using machine learning." PNAS.
- Nie & Wager (2021). "Quasi-oracle estimation of heterogeneous treatment effects." Biometrika.

### GATE Analysis Guides
- Chernozhukov et al. (2018). "Generic machine learning inference on heterogeneous treatment effects." arXiv.
- Kennedy (2020). "Towards optimal doubly robust estimation of heterogeneous causal effects." arXiv.

### Propensity Score Methods
- Austin (2011). "An introduction to propensity score methods for reducing confounding." Multivariate Behavioral Research.
- Rosenbaum & Rubin (1983). "The central role of the propensity score in observational studies." Biometrika.

### TBI Rehabilitation Literature
- [Your key references here]

---

## üîÑ Version History

- **v1.0.0** (2025-XX-XX): Initial public release
  - IHDP validation code
  - Siamese baseline comparison
  - GATE visualization tools
  - Comprehensive documentation

---

## ‚ö° Quick Reference

### Run Everything

```bash
# Install dependencies
pip install -r requirements.txt

# Run IHDP validation
python gate_ite_validation_upgraded.py

# Compare with baseline
python siamese_network_fixed.py

# Generate plots
python simple_gate_plots.py
```

### Key Metrics Thresholds

| Metric | Random | Okay | Good | Excellent |
|--------|--------|------|------|-----------|
| sqrt(PEHE) | >3.0 | 2.0-3.0 | 1.0-2.0 | **<0.6** |
| Correlation | <0.1 | 0.1-0.5 | 0.5-0.8 | **>0.8** |
| Sign Agreement | ~50% | 60-80% | 80-95% | **>95%** |

**Our result:** sqrt(PEHE) = 0.365, Correlation = 0.85, Sign Agreement = 99.2% ‚Üí **Excellent**

---

**Last Updated:** 2025-01-XX
